[HTML][HTML] Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy

DH Upton, C Ung, SM George, M Tsoli, M Kavallaris… - Theranostics, 2022 - ncbi.nlm.nih.gov
Despite significant advances in research, the prognosis for both primary and secondary
brain cancers remains poor. The blood-brain barrier (BBB) is a complex and unique semi …

Nanoparticle drug delivery system for glioma and its efficacy improvement strategies: a comprehensive review

J Li, J Zhao, T Tan, M Liu, Z Zeng, Y Zeng… - International Journal …, 2020 - Taylor & Francis
Gliomas are the most common tumor of the central nervous system. However, the presence
of the brain barrier blocks the effective delivery of drugs and leads to the treatment failure of …

Klotho, stem cells, and aging

A Bian, JA Neyra, M Zhan, MC Hu - Clinical Interventions in Aging, 2015 - Taylor & Francis
Aging is an inevitable and progressive biological process involving dysfunction and
eventually destruction of every tissue and organ. This process is driven by a tightly regulated …

Conditioned media from human adipose tissue‐derived mesenchymal stem cells and umbilical cord‐derived mesenchymal stem cells efficiently induced the apoptosis …

C Yang, D Lei, W Ouyang, J Ren, H Li… - BioMed research …, 2014 - Wiley Online Library
Human mesenchymal stem cells (MSCs) have an intrinsic property for homing towards
tumor sites and can be used as tumor‐tropic vectors for tumor therapy. But very limited …

Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in …

S Aroui, B Aouey, Y Chtourou, AC Meunier… - Chemico-biological …, 2016 - Elsevier
Abstract Naringin (4′, 5, 7-trihydroxyflavanone 7-rhamnoglucoside), a natural flavonoid,
has pharmacological properties. In the present study, we investigated the anti-metastatic …

Functional nanoparticles in targeting glioma diagnosis and therapies

M Li, H Deng, H Peng, Q Wang - Journal of nanoscience and …, 2014 - ingentaconnect.com
Successful therapy and diagnosis of glioma is one of the biggest challenges in the
biomedical fields. The incidence is growing gradually around the world. Annually, there are …

Penetrating the blood–brain barrier: promise of novel nanoplatforms and delivery vehicles

IU Ali, X Chen - ACS nano, 2015 - ACS Publications
Multifunctional nanoplatforms combining versatile therapeutic modalities with a variety of
imaging options have the potential to diagnose, monitor, and treat brain diseases. The …

The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma

Q Yue, X Zhang, H Ye, Y Wang, Z Du, Y Yao… - Journal of neuro …, 2014 - Springer
Abstract Forkhead box protein 3 (Foxp3) is known as a specific marker for regulatory T cells
which contribute to immunosuppression in tumor microenvironment. However, existing …

[HTML][HTML] Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling

PCH Cai, L Shi, VWS Liu, HWM Tang, IJ Liu… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Transforming growth factor (TGF)-β-activating kinase 1 (TAK1) is a serine/threonine kinase
which is frequently associated with human cancer progression. However, its functional role …

Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme

EF Da Silveira, JM Chassot, FC Teixeira… - Investigational new …, 2013 - Springer
Glioblastoma multiforme (GBM) is the worst and most common brain tumor, characterized by
high proliferation and invasion rates. Nanoparticles of biodegradable polymers for …